Nautilus Biotechnology, Inc. (NAUT)
2.82
-0.07
(-2.42%)
USD |
NASDAQ |
Feb 20, 16:00
2.83
+0.01
(+0.35%)
After-Hours: 20:00
Nautilus Biotechnology Total Assets (Quarterly) : 200.92M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nephros, Inc. | 13.25M |
| Prelude Therapeutics, Inc. | 94.76M |
| Pyxis Oncology, Inc. | 105.60M |
| ProKidney Corp. | 351.61M |
| Neumora Therapeutics, Inc. | 177.83M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.78M |
| Shareholders Equity (Quarterly) | 169.14M |
| Debt to Equity Ratio | 0.1597 |
| Current Ratio | 14.95 |
| Net Debt Paydown Yield | 1.05% |